| EXENATIDE SYNTHETIC | Astrazeneca | ||
| 2MG ; FOR SUSPENSION,EXTENDED RELEASE |
Less Than $1000 mn
|
||
| None | None | ||
|
Less Than 5
|
None | ||
| None | None | ||
| BYDUREON BCISE is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus. | |||
|
Yes
| |||
| BYDUREON PEN | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||
| ************* ********* **** ********** ***** ******* | ****** *** ************* ***** **** * *****-******* ******* ** *********** ***** | ************* ********* **** ********** ***** ******* | ************* ********* **** ********** ***** ******* | ****** *** ************* ***** **** * *****-******* ******* ** *********** ***** | ****** *** ************* * ***** ****** ********* **** * *****-******* ******* | ************* ****** **** ******* ********* | ****** ****** *** * ***-******* ******* | ********** ****** ***** ******* ****, *********** ******* ******* ******, *** ******** ******* ****** **** | ******* ********** ** ******* ****** | ******* ********** ** ******* ****** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|